Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06310512
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-12-18
Brief Title:
Efficacy of Pharmacist Interventions Through the Medication Therapy Management Pathway in Hypertensive Patients
Sponsor:
Beijing Anzhen Hospital
Organization:
Beijing Anzhen Hospital
Study Overview
Official Title:
Efficacy of Pharmacist Interventions Through the Medication Therapy Management Pathway in Hypertensive PatientsA Prospective Multicenter Randomized Controlled Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PharmMTMH
Brief Summary:
The goal of this Randomized Controlled Trial is to carry out in adult patients with primary hypertension whose blood pressure control is not up to standard The main question it aims to answer are
To explore the effect of pharmacists implementation of the medication therapy management pathway in hypertensive patientson the patients with hypertension
Participants will receive structured drug treatment management at the first diagnosis During on-site follow-up in the first third and sixth months as well as telephone follow-up in the second week second and fourth months patients will be evaluated corresponding information will be collected and possible interventions will be taken
Researchers will compare the non intervention group to see if patients blood pressure will also be reduced without intervention
To explore the effect of pharmacists implementation of the medication therapy management pathway in hypertensive patientson the patients with hypertension
Participants will receive structured drug treatment management at the first diagnosis During on-site follow-up in the first third and sixth months as well as telephone follow-up in the second week second and fourth months patients will be evaluated corresponding information will be collected and possible interventions will be taken
Researchers will compare the non intervention group to see if patients blood pressure will also be reduced without intervention
Detailed Description:
The purpose of this study is to explore the effectiveness safety and cost-effectiveness of pharmacists implementing the Drug Treatment Management Pathway in the treatment of hypertension patients This trial is a prospective multi-center randomized controlled study We plan to enroll 420 patients with primary hypertension who are over 18 years old and whose blood pressure control is not up to standard Qualified participants who meet the inclusion and exclusion criteria were randomly divided into an intervention group of 280 cases and a non intervention group of 140 cases in a 21 ratio
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None